# Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza

> **NCT01056380** · PHASE2 · TERMINATED · sponsor: **Romark Laboratories L.C.** · enrollment: 79 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Nitazoxanide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01056380
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 79 (ACTUAL)
- **Why stopped:** Insufficient enrollment during 2009-2010 flu season, new study initiated.
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056380, "Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01056380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*